secwatch.observer — SEC 8-K summary
======================================

Issuer:     Rapport Therapeutics, Inc. (RAPP)
CIK:        0002012593
Form:       8-K
Filed at:   2025-06-18T23:59:59+00:00
Accession:  0000950170-25-087921
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Rapport Therapeutics stockholders re-elect three Class I directors and ratify PwC as auditor
--------------------------------------------------------------------------------

- Reid Huber, Ph.D., John Maraganore, Ph.D., and Wendy B. Young, Ph.D. elected as Class I directors for terms expiring 2028.
- Director votes: Huber 31,146,580 for; Maraganore 31,222,571 for; Young 31,783,990 for.
- Ratification of PricewaterhouseCoopers LLP as independent auditor passed with 32,804,657 votes for, 112,489 against.
- Meeting held June 17, 2025; 36,497,555 shares outstanding and entitled to vote.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2012593/000095017025087921/0000950170-25-087921-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2012593/000095017025087921/rapp-20250617.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-087921

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer